Meaning the drug Prolanta doesnt really exist? Sorry, but thats not the case.
In fact, I believe there's enough material right now on Prolanta that ONCX should be considered. For a phase 1 company observing evidence of efficacy in late stage, pretreated ovarian cancer patients using low dose Prolanta without Chemo, thats significant stuff especially considering ONCX's valuation
Theres quite a bit more about Prolanta available from the right sources. A capable person conducting DD can find this out
What I havent found "officially" is the exact evidence of efficacy.